x
0 Activities
0 Activities
No Saved Activities
Please wait
Home
Education
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
Search Education
Register
Contact Us
Login
Login
Remember Me
Log in
Create an account
Forgot your password?
Search
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
All France Foundation Content
Credit Type
Format
Credits
Specialty Area
Allergy/Clinical Immunology
Hepatology
Blood Management
Cardiology
Dermatology
Endocrinology
Epileptology
Family Medicine
Gastroenterology
Genetic Counselor
Genomic Medicine
Hematology
Hospice/Palliative Care
Hospitalist
Internal Medicine
Medical Laboratory Scientist
Neonatal/Perinatal
Neurology
Neuromuscular Specialist
Neuropsychology
Neurosurgery
Nurse
Nurse Practitioner
Nutrition
Ob/Gyn & Women's Health
Occupational Therapy
Oncology
Opthalmology
Orthopedic Surgery
Pediatrics
Pharmacist
Physical Medicine & Rehabilitation
Physician Assistant
Psychiatry/Mental Health
Pulmonary
Radiology
Rheumatology
Disease Area
Start
«
1
2
3
4
»
End
Page 3 of 4
Results 151 - 225 of 289
15
30
60
75
150
Approved Medications for the Treatment of Severe Asthma
Engage Your Patients in Shared Decision-Making
Is It IPF or Cardiovascular Disease?
Interstitial Pneumonia with Autoimmune Features
How to Identify Progressive Fibrosing ILD
When Is It a Connective Tissue Disease?
How to Use IPF Guidelines to Make a Diagnosis
Advanced Care Planning and Palliative Care Models for Patients with IPF
Dyspnea Assessment in Patients with IPF
Which Patients with IPF Should be on Antifibrotics?
The Impact of Anticoagulation Use on IPF Patient Outcomes
Patient-Centered Outcomes for Patients with IPF: Activity Monitoring
Connective Tissue Disease-Related ILD is Now in the Limelight
Biomarkers in IPF and Other ILDs
Evaluation and Diagnosis of IPF
Initial Treatment Decisions of IPF
The Changing Landscape of SMA–Updates from Anaheim, CA
What if President Calvin Coolidge Was Your Asthma Patient?
Optimizing Management of IPF
New Concepts in the Pathobiology of Asthma
What are the Most Exciting Things Happening in Pulmonary Disease?
When Is a Cough Not Just a Cough?
Diagnosing ILDs Such as IPF and More
Beyond the Basics: Complex ILD Cases
PowerPoint Slides: Achieving Better Control of Severe Asthma
How Would You Manage President Theodore Roosevelt’s Asthma Today?
Eugene’s U(I)P-Hill Battle
Is Mary’s PAH Making You Dizzy?
Jeff’s COPD is No Smoke!
Clearing the Air on Chuck’s Asthma
Shedding Light on Jane’s ILD Diagnosis
When Should You Consider Palliative Care in the Patient Journey?
What is Your Treatment Recommendation for Sandra’s CTEPH?
Tracy Has Chest Palpitations and Cough: What Does Her Imaging Tell Us?
New Tools to Improve the Diagnosis of IPF vs Other ILDs
New Research on Therapies for Patients with Pulmonary Fibrosis
The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD
2019 Summer Pulmonary Updates: The Experts Weigh In
U.S. Presidents with Severe Asthma: Endotypes and Precision Medicine
Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease
Reporting HRCT Findings for ILD from a Multidisciplinary Team
A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story
How Pulmonary Arterial Hypertension Has Changed Iain’s Life
SMA: Data, Insights and Practice
From Bench to Bedside: Gene Therapy Approaches for Rare Diseases
Management of Mycobacterium Abscessus Lung Disease
Difficult to Treat Mycobacterium Avium Complex Lung Disease
Management of Mycobacterium Avium Complex Lung Disease
The Latest from a Recent Pulmonary Conference in San Antonio
Updates in Inoperable CTEPH
The Importance of Early Integration of Palliative Care
Management of IPF Patients in 2018
Updates in the Diagnosis of ILD and the Role of Cryobiopsy
Overview of the Latest Clinical Trials in IPF
Evolution of Antifibrotic Therapy in IPF
Take Home Messages from the 2018 CHEST Annual Meeting
What We’re Learning from the IPF-PRO Registry
Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines
Emerging Treatments for NTM Lung Disease
Nontuberculous Mycobacteria Case 2: Alan
NTM and Treatment Strategies for Patients with Cavitary Disease
New Findings in the Treatment of MAC Lung Disease
Why You Should Pay Attention to NTM Treatment Guidelines
Which of Your Patients Are at Risk for NTM?
Practice Improvement through ILD Centers and Community Partnerships
Improving the Care for IPF Patients Using a Team-Based Approach
An Early Integrated Palliative Care Delivery Model for Patients with IPF
Treatment Challenges with MAC Lung Disease
Nontuberculous Mycobacteria: Summary
Treatment Challenges with MABC Lung Disease
Nontuberculous Mycobacteria Case 1: Maria
NTM – To Treat or Not to Treat
Goals of NTM Treatment
Guideline-recommended Treatments for NTM
Diagnosis of NTM
Start
«
1
2
3
4
»
End
Page 3 of 4
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA
Search
Home
Education
Register
Contact Us
Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our
Privacy Policy
.
I accept